BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37643197)

  • 1. Identification of MKI67, TPR , and TCHH Mutations as Prognostic Biomarkers for Patients With Defective Mismatch Repair Colon Cancer Stage II/III.
    Lv J; Li W; Wang X; Guo L; Wang D; Zhang Y; Yu J; Chen T; Niu B; Wang X; Liu Z
    Dis Colon Rectum; 2023 Nov; 66(11):1481-1491. PubMed ID: 37643197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Mismatch Repair-Deficient Colon Cancer in Relation to Mismatch Repair Protein Loss, Hypermethylation Silencing, and Constitutional and Biallelic Somatic Mismatch Repair Gene Pathogenic Variants.
    Keshinro A; Ganesh K; Vanderbilt C; Firat C; Kim JK; Chen CT; Yaeger R; Segal NH; Gonen M; Shia J; Stadler ZK; Weiser MR
    Dis Colon Rectum; 2023 Apr; 66(4):549-558. PubMed ID: 35724254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
    Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
    Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
    Kyong Shin J; Ah Park Y; Wook Huh J; Hyeon Yun S; Cheol Kim H; Yong Lee W; Hyung Kim S; Yun Ha S; Cho YB
    Dis Colon Rectum; 2023 Aug; 66(8):e801-e808. PubMed ID: 35394982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease.
    Hajirawala LN; Yi Y; Herritt BC; Laurent ME; Klinger AL; Orangio GR; Davis KG; Barton JS
    Dis Colon Rectum; 2023 Aug; 66(8):1076-1084. PubMed ID: 35239528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Mucinous Adenocarcinoma in Stage II and III Colon Cancer.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park Y; Shin JK
    Dis Colon Rectum; 2023 Nov; 66(11):1473-1480. PubMed ID: 37260257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
    Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
    Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Characteristics of Patients With Colorectal Cancer Who Have Benign Mesenteric Lymph Node Enlargement: A Multi-institutional Cohort Study.
    Huang X; Yang Y; Liu Q; Tang X; Shi J; Qu H; Chen X; Gong L; Wang S; Tang S; Wang P; Tang L; Hu D; Yin X; Guan Y; Kong D; Tian F
    Dis Colon Rectum; 2022 Jun; 65(6):804-816. PubMed ID: 34759241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Value of Micropapillary Pattern in Colon Cancer and Its Role as a High-Risk Feature in Patients With Stage II Disease.
    Pyo DH; Kim SH; Shin JK; Park Y; Huh JW; Kim HC; Yun SH; Lee WY; Cho YB
    Dis Colon Rectum; 2023 Nov; 66(11):1462-1472. PubMed ID: 37339285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Microsatellite Status Associated With Prognosis in Stage II Colon Cancer With High-Risk Features?
    Cavallaro PM; Stafford C; Cauley CE; Berger DL; Bordeianou L; Kunitake H; Francone T; Ricciardi R
    Dis Colon Rectum; 2021 May; 64(5):545-554. PubMed ID: 33939386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
    Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Marker Trajectories and Survival Analysis in Patients With Normal Carcinoembryonic Antigen Ranges After Colorectal Cancer Resection.
    Chern YJ; Hsu HY; Hsu YJ; Hsu LY; Tsai WS; Liao CK; Jong BK; You JF
    Dis Colon Rectum; 2024 Jan; 67(1):62-72. PubMed ID: 37594896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Characteristics of Anastomotic Recurrence After Curative Resection for Colorectal Cancer: Comparison With Nonanastomotic Local Recurrences.
    Matsunaga K; Sasaki K; Nozawa H; Kawai K; Murono K; Emoto S; Kishikawa J; Ozawa T; Yokoyama Y; Abe S; Nagai Y; Anzai H; Sonoda H; Hata K; Ishihara S
    Dis Colon Rectum; 2023 Oct; 66(10):e1014-e1022. PubMed ID: 36649156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Tumor Location on Outcome After Laparoscopic Low Rectal Cancer Surgery: A Propensity Score Matching Analysis.
    Wu Q; Jin Z; Zhang X; Deng X; Peng Y; Wang Z
    Dis Colon Rectum; 2022 May; 65(5):672-682. PubMed ID: 35394940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
    O'Brien SJ; Kalbfleisch T; Srivastava S; Pan J; Rai S; Petras RE; Ronquillo N; Polk HC; Galandiuk S
    Dis Colon Rectum; 2021 Sep; 64(9):1083-1095. PubMed ID: 33990498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline Cancer Risk Profiles of Patients With Young-Onset Colorectal Cancer: Findings From a Prospective Universal Germline Testing and Telegenetics Program.
    You YN; Moskowitz JB; Chang GJ; Mork ME; Rodriguez-Bigas MA; Bednarski BK; Messick CA; Tillman MM; Skibber JM; Nguyen ST; Kopetz S; Vilar E
    Dis Colon Rectum; 2023 Apr; 66(4):531-542. PubMed ID: 35195555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Insight Into the Driver Mutations and Molecular Mechanisms Underlying Mucinous Adenocarcinoma of the Rectum.
    Reynolds IS; O'Connell E; Fichtner M; Blümel A; Mason SE; Kinross J; McNamara DA; Kay EW; O'Connor DP; Das S; Burke JP; Prehn JHM
    Dis Colon Rectum; 2021 Jun; 64(6):677-688. PubMed ID: 33955407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
    Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
    Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
    Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery.
    Eckberg SE; Dahlberg MJA; der Hagopian OS; Farahnak P; Sandblom GK; Nordenvall CAM; Everhov ÅH
    Dis Colon Rectum; 2021 Feb; 64(2):171-180. PubMed ID: 33315716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.